Position | Description | PubMed ID | GlyTouCan ID | Source |
---|---|---|---|---|
478 |
|
|||
481 |
|
|||
485 |
|
Pathway Name | Organism |
---|---|
Constitutive Signaling by Aberrant PI3K in Cancer | Homo sapiens |
DAP12 signaling | Homo sapiens |
Downstream TCR signaling | Homo sapiens |
Downstream signal transduction | Homo sapiens |
Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | Homo sapiens |
GPVI-mediated activation cascade | Homo sapiens |
IRS-mediated signalling | Homo sapiens |
Interleukin receptor SHC signaling | Homo sapiens |
Interleukin-3, Interleukin-5 and GM-CSF signaling | Homo sapiens |
Nephrin family interactions | Homo sapiens |
DO ID | Disease Name | Source |
---|---|---|
DOID:0111136 | congenital generalized lipodystrophy type 2 | |
DOID:0111137 | congenital generalized lipodystrophy type 3 | |
DOID:0111138 | congenital generalized lipodystrophy type 4 | |
DOID:0111147 | angioimmunoblastic T-cell lymphoma | |
DOID:0111152 | multicentric Castleman disease | |
DOID:0111252 | vestibular schwannomatosis | |
DOID:0111253 | neurofibromatosis 1 | |
DOID:0111343 | lateral meningocele syndrome | |
DOID:0111412 | exudative vitreoretinopathy 1 | |
DOID:0111454 | SHORT syndrome |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024